Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / AstraZeneca

Clinicaltrial registered18 Nov 2026

AstraZeneca

18 Nov 2026: Trial registered · A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
18 Nov 2026
Title
A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia
Conditions
Hyperkalemia
Phase
Phase 4
Study Type
Interventional
Status
Recruiting
Countries
India
Country
India
Reference
NCT07944378
Location
India
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at AstraZeneca

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for AstraZeneca in our registers.

More from India

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.